Patents by Inventor Peter Charles Harris

Peter Charles Harris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polycystic kidney disease 12 gene and uses thereof
    Patent number: 6656681
    Abstract: The present invention relates to the polycystic kidney disease 1 (PKD1) gene and its nucleic acid sequence, mutations thereof in patients having PKD1-associated disorders, the protein encoded by the PKD1 gene or its mutants, and their uses in disease diagnosis and therapy.
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: December 2, 2003
    Inventors: Peter Charles Harris, Belen Peral, Christopher J. Ward, James Hughes, Martin Hendrik Breuning, Dorothea Johanna Maria Peters, Jeroen Hendrik Roelfsema, Julian Sampson, Dirkje Jorijntje Johanna Halley, Mark David Nellist, Lambertus Antonius Jacobus Janssen, Ajenne Lique Wilhelma Hesseling
  • Polycystic kidney disease 1 gene and uses thereof
    Patent number: 6485960
    Abstract: The present invention relates to the polycystic kidney disease 1 (PKD1) gene and its nucleic acid sequence, mutations thereof in patients having PKD1-associated disorders, the protein encoded by the PKD1 gene or its mutants, and their uses in disease diagnosis and therapy.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: November 26, 2002
    Assignee: Medical Research Council
    Inventors: Peter Charles Harris, Belen Peral, Christopher J. Ward, James Hughes, Martin Hendrik Breuning, Dorothea Johanna Maria Peters, Jeroen Hendrik Roelfsema, Julian Sampson, Dirkje Jorijntje Johanna Halley, Mark David Nellist, Lambertus Antonius Jacobus Janssen, Ajenne Lique Wilhelma Hesseling
  • Polycystic kidney disease 1 gene and uses thereof
    Patent number: 6380360
    Abstract: The present invention relates to the polycystic kidney disease 1 (PKD1) gene and its nucleic acid sequence, mutations thereof in patients having PKD1-associated disorders, the protein encoded by the PKD1 gene or its mutants, and their uses in disease diagnosis and therapy.
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: April 30, 2002
    Assignee: Medical Research Council
    Inventors: Peter Charles Harris, Belen Peral, Christopher J. Ward, James Hughes, Martin Hendrik Breuning, Dorothea Johanna Maria Peters, Jeroen Hendrik Roelfsema, Julian Sampson, Dirkje Jorijntje Johanna Halley, Mark David Nellist, Lambertus Antonius Jacobus Janssen, Ajenne Lique Wilhelma Hesseling
  • Tuberous sclerosis 2 gene and uses thereof
    Patent number: 6232452
    Abstract: Tuberous sclerosis (TSC) is an autosomal dominant disorder characterised by widespread development of growths in many tissues and organs. A gene (TSC2) is identified on chromosome 16 which is mutated in TSC and which may behave as a tumour suppressor. Screening of actual or suspected TSC patients for normal or mutated TSC2 can be used for diagnostic purposes. TSC2 protein (tuberin) may be used to treat or prevent unrestrained cell division and/or tumour development in patients with or without TSC.
    Type: Grant
    Filed: October 1, 1996
    Date of Patent: May 15, 2001
    Inventors: Julian R. Sampson, Mark David Nellist, Phillip Brook-Carter, Magitha Maheshwar, Dirkje Jorijntje Johanna Halley, Lambertus Antonius Jacobus Janssen, Arjenne Lique Wilhelma Hesseling, Anna Maria Wilhelmina van den Ouweland, Peter Charles Harris, Christopher James Ward, Martin Hendrik Breuning, Jeroen Hendrik Roelfsema
  • Tuberous sclerosis 2 gene and uses thereof
    Patent number: 6207374
    Abstract: Tuberous sclerosis (TSC) is an autosomal dominant disorder characterised by widespread development of growths in many tissues and organs. A gene (TSC2) is identified on chromosome 16 which is mutated in TSC and which may behave as a tumour suppressor. Screening of actual or suspected TSC patients for normal or mutated TSC2 can be used for diagnostic purposes. TSC2 protein (tuberin) may be used to treat or prevent unrestrained cell division and/or tumour development in patients with or without TSC.
    Type: Grant
    Filed: March 18, 1998
    Date of Patent: March 27, 2001
    Assignee: Medical Research Council
    Inventors: Julian R. Sampson, Mark David Nellist, Phillip Brook-Carter, Magitha Maheshwar, Dirkje Jorijnte Johanna Halley, Lambertus Antonius Jacobus Janssen, Arjenne Lique Wilhelma Hesseling, Anna Maria Wilhelmina van den Ouweland, Peter Charles Harris, Christopher James Ward, Martin Hendrik Breuning, Jeroen Hendrik Roelfsema